CurrentCardio
Get Weekly

Topic · page 33 of 49

Heart failure & cardiomyopathies

HFrEF, HFmrEF, HFpEF, acute HF, cardiomyopathies (HCM, DCM, amyloidosis), myocarditis and inflammatory cardiomyopathy, devices for HF, HF prognosis

Briefs 1,281–1,320 of 1,928 placed here, newest publication first

Briefs in Heart failure & cardiomyopathies

Newest publication first

  1. Circulation

    Effects of Tirzepatide on the Clinical Trajectory of Patients With Heart Failure, Preserved Ejection Fraction, and Obesity

    Secondary analysis

  2. Circulation

    Long-Term Efficacy and Safety of Acoramidis in ATTR-CM: Initial Report From the Open-Label Extension of the ATTRibute-CM Trial

    Randomised controlled trial

  3. Circulation

    Mavacamten in Patients With Hypertrophic Cardiomyopathy Referred for Septal Reduction: Week 128 Results From VALOR-HCM

    Randomised controlled trial

  4. J Am Coll Cardiol

    Sodium Zirconium Cyclosilicate for Management of Hyperkalemia During Spironolactone Optimization in Patients With Heart Failure

    Randomised controlled trial

  5. Nat Med

    Effects of tirzepatide on circulatory overload and end-organ damage in heart failure with preserved ejection fraction and obesity: a secondary analysis of the SUMMIT trial

    Secondary analysis

  6. N Engl J Med

    Tirzepatide for Heart Failure with Preserved Ejection Fraction and Obesity

    Randomised controlled trial

  7. JACC Heart Fail

    Association of Histologic Findings With Long-Term Outcomes in Symptomatic Obstructive Hypertrophic Cardiomyopathy Patients Undergoing Surgical Myectomy

    Cohort study

  8. Circulation

    Unipolar Voltage Mapping to Predict Recovery of Left Ventricular Ejection Fraction in Patients With Recent-Onset Nonischemic Cardiomyopathy

    Secondary analysis

  9. Circulation

    Gene Therapy in Cardiovascular Disease: Recent Advances and Future Directions in Science: A Science Advisory From the American Heart Association

    Guideline or statement

  10. Eur J Heart Fail

    Preventive Catheter Ablation for Ventricular Arrhythmias in Patients with End-Stage Heart Failure Referred for Heart Transplantation Evaluation: Rationale for and Design of the CASTLE-VT Trial

    Trial design

  11. Eur Heart J

    Centrally adjudicated vs. investigator-reported outcomes in randomized heart failure trials

    Meta-analysis

  12. Circulation

    Exercise Training in Patients With Hypertrophic Cardiomyopathy Without Left Ventricular Outflow Tract Obstruction: A Randomized Clinical Trial

    Randomised controlled trial

  13. BMJ

    SGLT-2 inhibitors and mortality among patients with heart failure with reduced ejection fraction: linked database study

    Cohort study

  14. JACC Heart Fail

    Hospitalized Advanced Heart Failure With Preserved vs Reduced Left Ventricular Ejection Fraction: A Global Perspective

    Cohort study

  15. JACC Heart Fail

    The Clinical Trajectory of NYHA Functional Class I Patients With Obstructive Hypertrophic Cardiomyopathy

    Cohort study

  16. Eur J Heart Fail

    Long-Term Clinical Outcomes and Healthcare Resource Utilization in Male and Female Patients Following Hospitalization for Heart Failure

    Secondary analysis

  17. JAMA Cardiol

    Hospital Heart Failure Medical Therapy Score and Associated Clinical Outcomes and Costs

    Cohort study

  18. JAMA Cardiol

    Myocardial Scarring and Sudden Cardiac Death in Young Patients With Hypertrophic Cardiomyopathy: A Multicenter Cohort Study

    Cohort study

  19. JAMA Cardiol

    Prevalence, Cardiac Phenotype, and Outcomes of Transthyretin Variants in the UK Biobank Population

    Cohort study

  20. JAMA Cardiol

    Redefining Cardiac Involvement and Targets of Treatment in Systemic Immunoglobulin AL Amyloidosis

    Cohort study

  21. Europace

    Drug therapy and catheter ablation for management of arrhythmias in continuous flow left ventricular assist device’s patients: a Clinical Consensus Statement of the European Heart Rhythm Association and the Heart Failure Association of the ESC

    Guideline or statement

  22. Eur J Heart Fail

    Vericiguat Global Study in Participants with Chronic Heart Failure: Design of the VICTOR Trial

    Trial design

  23. J Am Coll Cardiol

    Transcatheter Aortic Valve Replacement in Patients With Systolic Heart Failure and Moderate Aortic Stenosis: TAVR UNLOAD

    Randomised controlled trial

  24. Eur J Heart Fail

    Trends in Heart Failure Mortality in Sweden Between 1997 and 2022

    Cohort study

  25. JACC Heart Fail

    Uric Acid and SGLT2 Inhibition With Empagliflozin in Heart Failure With Preserved Ejection Fraction: The EMPEROR-Preserved Trial

    Secondary analysis

  26. JACC Heart Fail

    Automated Identification of Heart Failure With Reduced Ejection Fraction Using Deep Learning-Based Natural Language Processing

    Diagnostic or prognostic study

  27. Europace

    Prediction of new-onset atrial fibrillation in patients with hypertrophic cardiomyopathy using plasma proteomics profiling

    Cohort study

  28. Eur J Heart Fail

    Long-Term Exposure to Fine Particulate Matter Constituents, Genetic Susceptibility, and Incident Heart Failure Among 411 807 Adults

    Cohort study

  29. Eur J Heart Fail

    The Global, Regional, and National Burden of Myocarditis in 204 Countries and Territories, 1990–2021: Results From the Global Burden of Disease Study 2021

    Research article

  30. Eur J Heart Fail

    Visit-to-Visit Changes in Heart Rate in Heart Failure: A Pooled Participant-Level Analysis of the PARADIGM-HF and PARAGON-HF Trials

    Meta-analysis

  31. Circulation

    Clinical Correlates and Prognostic Impact of Cognitive Dysfunction in Patients With Heart Failure and Preserved Ejection Fraction: Insights From PARAGON-HF

    Secondary analysis

  32. JACC Heart Fail

    Genetic Landscape of Patients With Dilated Cardiomyopathy and a Systemic Immune-Mediated Disease

    Cohort study

  33. Europace

    Comprehensive vs. standard remote monitoring of cardiac resynchronization devices in heart failure patients: results of the ECOST-CRT study

    Randomised controlled trial

  34. JACC Heart Fail

    Cardiac Resynchronization Therapy in Ischemic Versus Nonischemic Cardiomyopathy: Patient-Level Meta-Analysis of 7 Randomized Clinical Trials

    Meta-analysis

  35. Europace

    Multipoint pacing is associated with improved prognosis and cardiac resynchronization therapy response: MORE-CRT MPP randomized study secondary analyses

    Secondary analysis

  36. Eur J Heart Fail

    Diuretic Dosing and Outcomes with Torsemide and Furosemide Following Hospitalization for Heart Failure: The TRANSFORM-HF Trial

    Secondary analysis

  37. J Am Coll Cardiol

    Family Screening in Hypertrophic Cardiomyopathy: Identification of Relatives With Low Yield From Systematic Follow-Up

    Cohort study

  38. J Am Coll Cardiol

    Prevalence and Impact of Recurrent Rejection on Pediatric Heart Transplant Recipients: A PHTS Multi-Institutional Analysis

    Cohort study

  39. Circulation

    Long-Term Outcomes After Septal Reduction Therapies in Obstructive Hypertrophic Cardiomyopathy: Insights From the SHARE Registry

    Cohort study

  40. Eur J Heart Fail

    Multicentre, Randomized, Double-Blind, Prospective Study on the Effects of ImmunoAdSorptiOn on Cardiac Function in Patients with Dilated CardioMyopathy (IASO-DCM): Rationale and Design

    Trial design

All 1,928 Briefs in ExploreShowing Briefs 1,281–1,320 of 1,928, newest first